Skip to content

Tuesday, February 7, 2023

Latest:

Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
Why women with heart issues are undertreated and have worse outcomes than men
Breakthrough epigenetic study can improve the power to predict disease risk
When visible meets invisible: the importance of psychological screening and intervention in pediatric dermatology

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

US FDA

Policywise

Direct-to-consumer BRCA testing: Can a reasonable decision still require caution?

March 21, 2018March 21, 201823andMe, BRCA, genetic testing, health policy, Mary Anderlik Majumder, US FDA

On March 6, the U.S. Food and Drug Administration (FDA) authorized 23andMe to expand its direct-to-consumer (DTC) genetic test to include selected variants in BRCA1

From the Labs Image of the Month

From the Labs: Adult-born neurons made the cover